This page lists the SEC filings reported by Novo Holdings A/S.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2022-02-02 | Novo Holdings A/S | Evotec SE | 17,894,807 | 10.2% | EDGAR |
| SC 13G | 2022-02-02 | Novo Holdings A/S | Exscientia plc | 13,086,600 | 11.0% | EDGAR |
| SC 13D/A | 2022-01-31 | Novo Holdings A/S | Aligos Therapeutics, Inc. | 1,950,000 | 4.9% | EDGAR |
| SC 13D/A | 2022-01-27 | Novo Holdings A/S | Reneo Pharmaceuticals, Inc. | 3,430,377 | 14.0% | EDGAR |
| SC 13D/A | 2021-12-20 | Novo Holdings A/S | Cyteir Therapeutics, Inc. | 4,840,413 | 13.6% | EDGAR |
| SC 13D/A | 2021-11-22 | Novo Holdings A/S | Bolt Biotherapeutics, Inc. | 4,503,991 | 12.0% | EDGAR |
| SC 13D/A | 2021-11-22 | Novo Holdings A/S | Nkarta, Inc. | 2,793,865 | 8.5% | EDGAR |
| SC 13D/A | 2021-11-22 | Novo Holdings A/S | SPRUCE BIOSCIENCES, INC. | 4,514,336 | 19.2% | EDGAR |
| SC 13D | 2021-11-10 | Novo Holdings A/S | IO Biotech, Inc. | 3,277,932 | 11.8% | EDGAR |
| SC 13G/A | 2021-11-02 | Novo Holdings A/S | Freeline Therapeutics Holdings plc | 1,785,563 | 5.0% | EDGAR |
| SC 13D/A | 2021-11-01 | Novo Holdings A/S | Morphic Holding, Inc. | 2,050,446 | 5.6% | EDGAR |
| SC 13D/A | 2021-11-01 | Novo Holdings A/S | Checkmate Pharmaceuticals, Inc. | 2,170,100 | 10.0% | EDGAR |
| SC 13G | 2021-10-27 | Novo Holdings A/S | MINERVA SURGICAL INC | 2,057,132 | 7.2% | EDGAR |
| SC 13G/A | 2021-09-20 | Novo Holdings A/S | Inogen Inc | 1,079,320 | 4.7% | EDGAR |
| SC 13D/A | 2021-08-24 | Novo Holdings A/S | Mirum Pharmaceuticals, Inc. | 2,445,147 | 8.0% | EDGAR |
| SC 13D/A | 2021-08-12 | Novo Holdings A/S | Morphic Holding, Inc. | 2,050,446 | 5.6% | EDGAR |
| SC 13D/A | 2021-07-30 | Novo Holdings A/S | Inozyme Pharma, Inc. | 1,167,706 | 5.0% | EDGAR |
| SC 13D | 2021-06-25 | Novo Holdings A/S | Cyteir Therapeutics, Inc. | 4,840,413 | 14.0% | EDGAR |
| SC 13D/A | 2021-06-21 | Novo Holdings A/S | Aligos Therapeutics, Inc. | 2,614,563 | 7.5% | EDGAR |
| SC 13D/A | 2021-05-21 | Novo Holdings A/S | SPRUCE BIOSCIENCES, INC. | 4,514,336 | 19.4% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.